Table 3 The VBIs among different groups during follow-up

From: Increased neonatal vaccine dose or booster immunization prevents hepatitis B vaccine breakthrough infection in children from HBsAg and HBeAg positive mothers

Timepoint of

Follow-up

10 μg HB vaccine

without booster group

10 μg HB vaccine with booster group

20 μg HB vaccine

without booster group

20 μg HB vaccine with booster group

P

n

VBI(%)

n

VBI(%)

n

VBI(%)

n

VBI(%)

2 y

138

11(8.0)

12

0

196

13(6.6)

6

0

0.826

3 y

117

10(8.5)

33

1(3.0)

181

7(3.9)

21

0

0.250

5 y

95

14(14.7)

55

2(3.6)

127

8(6.3)

75

3(4.0)

0.035

Back to article page